{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:24:42Z","timestamp":1792787082285,"version":"4.5.0"},"reference-count":37,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2014,12,21]],"date-time":"2014-12-21T00:00:00Z","timestamp":1419120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"K.U.Leuven","award":["Methusalem"],"award-info":[{"award-number":["Methusalem"]}]},{"name":"Shire-Movetis NV"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurogastroenterology Motil"],"published-print":{"date-parts":[[2015,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Approximately, 20\u201330% of patients with gastro\u2010esophageal reflux disease (\n                      <jats:styled-content style=\"fixed-case\">GERD<\/jats:styled-content>\n                      ) experience persistent symptoms despite treatment with proton pump inhibitors (\n                      <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>\n                      s). These patients may have underlying dysmotility; therefore, targeting gastric motor dysfunction in addition to acid inhibition may represent a new therapeutic avenue. The aim of this study was to assess the pharmacodynamic effect of the prokinetic agent revexepride (a 5\u2010\n                      <jats:styled-content style=\"fixed-case\">HT<\/jats:styled-content>\n                      <jats:sub>4<\/jats:sub>\n                      receptor agonist) in patients with\n                      <jats:styled-content style=\"fixed-case\">GERD<\/jats:styled-content>\n                      who have persistent symptoms despite treatment with a\n                      <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This was a phase II, exploratory, multicenter, randomized, placebo\u2010controlled, double\u2010blind, parallel\u2010group study in patients with\n                      <jats:styled-content style=\"fixed-case\">GERD<\/jats:styled-content>\n                      who experienced persistent symptoms while taking a stable dose of\n                      <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>\n                      s (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/ClinicalTrials.gov\">ClinicalTrials.gov<\/jats:ext-link>\n                      identifier: NCT01370863). Patients were randomized to either revexepride (0.5\u00a0mg, three times daily) or matching placebo for 4\u00a0weeks. Reflux events and associated characteristics were assessed by pH\/impedance monitoring and disease symptoms were assessed using electronic diaries and questionnaires.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Results<\/jats:title>\n                    <jats:p>In total, 67 patients were enrolled in the study. There were no significant differences between study arms in the number, the mean proximal extent or the bolus clearance times of liquid\u2010containing reflux events. Changes from baseline in the number of heartburn, regurgitation, and other symptom events were minimal for each treatment group and no clear trends were observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions &amp; Inferences<\/jats:title>\n                    <jats:p>No clear differences were seen in reflux parameters between the placebo and revexepride groups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/nmo.12484","type":"journal-article","created":{"date-parts":[[2014,12,21]],"date-time":"2014-12-21T19:31:18Z","timestamp":1419190278000},"page":"258-268","source":"Crossref","is-referenced-by-count":15,"title":["Randomized clinical trial: effect of the 5\u2010\n                    <scp>HT<\/scp>\n                    <sub>4<\/sub>\n                    receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite\n                    <scp>PPI<\/scp>\n                    treatment"],"prefix":"10.1111","volume":"27","author":[{"given":"J.","family":"Tack","sequence":"first","affiliation":[{"name":"Universitair Ziekenhuis Leuven Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Zerbib","sequence":"additional","affiliation":[{"name":"CHU de Bordeaux H\u00f4pital Saint Andr\u00e9 Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Blondeau","sequence":"additional","affiliation":[{"name":"Universitair Ziekenhuis Leuven Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. B.","family":"des Varannes","sequence":"additional","affiliation":[{"name":"Institut des Maladies de l'Appareil Digestif du Centre Hospitalier Universitaire de Nantes Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Piessevaux","sequence":"additional","affiliation":[{"name":"Cliniques Universitaires Saint\u2010Luc Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Borovicka","sequence":"additional","affiliation":[{"name":"Kantonsspital St Gallen St Gallen Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Mion","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon Digestive Physiology University Lyon Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fox","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology University Hospital Z\u00fcrich Zurich Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J.","family":"Bredenoord","sequence":"additional","affiliation":[{"name":"Academic Medical Center Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Louis","sequence":"additional","affiliation":[{"name":"CUB H\u00f4pital Erasme Universit\u00e9 Libre de Bruxelles Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dedrie","sequence":"additional","affiliation":[{"name":"Shire\u2010Movetis NV Turnhout Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hoppenbrouwers","sequence":"additional","affiliation":[{"name":"Shire\u2010Movetis NV Turnhout Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Meulemans","sequence":"additional","affiliation":[{"name":"Shire\u2010Movetis NV Turnhout Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rykx","sequence":"additional","affiliation":[{"name":"Shire\u2010Movetis NV Turnhout Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Thielemans","sequence":"additional","affiliation":[{"name":"Shire\u2010Movetis NV Turnhout Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ruth","sequence":"additional","affiliation":[{"name":"Shire\u2010Movetis NV Turnhout Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,12,21]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-009-1015-3"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.145581"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0b013e32833ae2be"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.24840"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1159\/000151254"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12252"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2005.pto_273.x"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-005-0033-x"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-999-0033-3"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199447010-00008"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.94266000.x"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.70.Suppl_5.S4"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03090.x"},{"key":"e_1_2_11_15_1","first-page":"171","article-title":"Prokinetic drug utility in the treatment of gastroesophageal reflux esophagitis: a systematic review of randomized controlled trials","volume":"1","author":"Manzotti ME","year":"2007","journal-title":"Open Med"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05086.x"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.087668"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00711.x"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.2.172"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01297443"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.033290"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-004-9567-x"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-004-8751-3"},{"key":"e_1_2_11_24_1","first-page":"A\u2010433","article-title":"Effect of AZD3355, a novel GABA(B) agonist, on reflux and lower esophageal sphincter function in patients with GERD with symptoms despite proton pump inhibitor treatment","volume":"58","author":"Boeckxstaens GE","year":"2009","journal-title":"Gut"},{"key":"e_1_2_11_25_1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/2229-3485.71856","article-title":"Sample size estimation in clinical trial","volume":"1","author":"Sakpal TV","year":"2010","journal-title":"Perspect Clin Res"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-010-9620-x"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200309000-00004"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.133470"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.01791.x"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02968.x"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03281.x"},{"key":"e_1_2_11_32_1","doi-asserted-by":"crossref","first-page":"S\u2010189","DOI":"10.1016\/S0016-5085(11)60762-2","article-title":"Responsiveness of regurgitation, dimensionalized by the Reflux Disease Questionnaire, to potent acid\u2010suppressing therapy","volume":"140","author":"Kahrilas P","year":"2011","journal-title":"Gastroenterology"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.01.014"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1155\/1997\/314839"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302737"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2011.08.017"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1443-9573.2006.00266.x"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2012.01888.x"}],"container-title":["Neurogastroenterology &amp; Motility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fnmo.12484","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/nmo.12484","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/nmo.12484","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/nmo.12484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T21:00:12Z","timestamp":1717621212000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/nmo.12484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,21]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.1111\/nmo.12484"],"URL":"https:\/\/doi.org\/10.1111\/nmo.12484","archive":["Portico"],"relation":{},"ISSN":["1350-1925","1365-2982"],"issn-type":[{"value":"1350-1925","type":"print"},{"value":"1365-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,21]]}}}